tm logo
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 05 Jun 2024

Last Applicant/ Owned by

2121 2nd St, STE C108

Davis

CA

95618

Serial Number

97590689 filed on 14th Sep 2022

Registration Number

N/A

Correspondent Address

John Gary Maynard, III

John Gary Maynard, III HUNTON ANDREWS KURTH LLP

RIVERFRONT PLAZA, EAST TOWER

RICHMOND, VA 23219-4074

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

Logo Mark Trademark Information

Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prev Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; Development of computer platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; Development of computer platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; Platform as a service (PAAS) featuring predictive, monitoring and diagnostic computer software platforms for caregivers and healthcare providers to monitor health and wellness of pregnant women, nursing mothers, caregivers, and their infants; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97590689

Mark Type

No Service Mark

Attorney Docket Number

No 084193.00002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

Legal History


Show more

Status DateAction Taken
12th Dec 2024SOU TEAS EXTENSION RECEIVED
12th Dec 2024TEAS STATEMENT OF USE RECEIVED
13th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Jun 2024SOU EXTENSION 1 GRANTED
05th Jun 2024SOU EXTENSION 1 FILED
05th Jun 2024SOU TEAS EXTENSION RECEIVED
12th Dec 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17th Oct 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Oct 2023PUBLISHED FOR OPPOSITION
27th Sep 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED